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We read with interest ‘‘Does Deworm-
ing Improve Growth and School Perfor-
mance in Children?’’ (published in this
issue [1]), a summary of the 2007
Cochrane systematic review by David
Taylor-Robinson and colleagues. Their
previous systematic review [2], published
in the BMJ, has been subject to substantial
criticism by various authors and institu-
tions [3–7]. Taylor-Robinson and col-
leagues have now responded to these
criticisms by updating the original Co-
chrane review to include a number of
recent trials and by giving more attention
to two of the previous criticisms, i.e.,
outcome after longer follow-up and addi-
tional analysis taking worm intensity and
prevalence into account.
We believe, however, that the current
updated review remains limited in scope
and does not bring substantially more
value to their first systematic review,
published in 2000 [1]. Our uneasiness
with the updated review continues to
reside in the use of a clinical epidemiolog-
ical approach applied to public health and
policymaking, and the fallacies that such
an approach is likely to bring about.
It is worth noticing in this respect that
another extensive review and meta-analy-
sis—including more studies, of which most
are overlapping with those included in the
Cochrane review—was published earlier
this year [8]. This review presents much
more conclusive evidence in favour of
systematic deworming, and also dedicates
a section to a comparison with the
Cochrane review conclusions. We believe
that the more firm conclusions by Hall et
al. are essentially due to (a) a more
cautious consideration of the particular
aspects of the transmission dynamics of
intestinal helminths; (b) the multi-factorial
origin of improvements to which deworm-
ing contributes; and (c) the cost–benefit
and public health policy rationale on
which the WHO recommendation in
favour of systematic deworming is based.
Public health policy setting indeed has to
go beyond the issue of whether a sacro-
sanct level of statistical significance is
reached on a limited number of (multi-
factorial) outcomes in a series of carefully
selected studies.
The World Health Organization
(WHO) is currently promoting the large-
scale implementation of ‘‘preventive che-
motherapy’’—i.e., the use of anthelmin-
thic drugs—at various intervals, either
alone or in combination depending on
disease endemicity—as a public health
tool for preventing morbidity due to
infection with more than one helminth at
a time [9]. Polyparasitism is indeed the
rule more than an exception in poor
settings. The preventive chemotherapy
approach should logically have a very
much enhanced impact at a minimal
increase in cost and should ease the
concerns of the Cochrane Collaboration
as to whether large-scale deworming is
worthwhile or not. We therefore look
forward to a first Cochrane systematic
review evaluating the comprehensive im-
pact of deworming in such a multi-disease
perspective.
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